gamma-Tocopherol
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- gamma-Tocopherol
- DrugBank Accession Number
- DB15394
- Background
gamma-Tocopherol is under investigation in clinical trial NCT00836368 (In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 416.6795
Monoisotopic: 416.36543078 - Chemical Formula
- C28H48O2
- Synonyms
- D-gamma-Tocopherol
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareOrlistat Orlistat can cause a decrease in the absorption of gamma-Tocopherol resulting in a reduced serum concentration and potentially a decrease in efficacy. - Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8EF1Z1238F
- CAS number
- 54-28-4
- InChI Key
- QUEDXNHFTDJVIY-DQCZWYHMSA-N
- InChI
- InChI=1S/C28H48O2/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-28(7)18-16-25-19-26(29)23(5)24(6)27(25)30-28/h19-22,29H,8-18H2,1-7H3/t21-,22-,28-/m1/s1
- IUPAC Name
- (2R)-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol
- SMILES
- CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
References
- General References
- Not Available
- External Links
- KEGG Compound
- C02483
- ChemSpider
- 83708
- 2368126
- ChEBI
- 18185
- ChEMBL
- CHEMBL2151591
- ZINC
- ZINC000004284471
- Wikipedia
- Gamma-Tocopherol
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 7.37e-06 mg/mL ALOGPS logP 8.81 ALOGPS logP 9.99 Chemaxon logS -7.8 ALOGPS pKa (Strongest Acidic) 10.47 Chemaxon pKa (Strongest Basic) -4.9 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 29.46 Å2 Chemaxon Rotatable Bond Count 12 Chemaxon Refractivity 130.33 m3·mol-1 Chemaxon Polarizability 54.12 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 226.4940469 predictedDarkChem Lite v0.1.0 [M-H]- 232.3438469 predictedDarkChem Lite v0.1.0 [M-H]- 226.8563469 predictedDarkChem Lite v0.1.0 [M-H]- 206.62073 predictedDeepCCS 1.0 (2019) [M+H]+ 225.8716469 predictedDarkChem Lite v0.1.0 [M+H]+ 230.6198469 predictedDarkChem Lite v0.1.0 [M+H]+ 232.7490469 predictedDarkChem Lite v0.1.0 [M+H]+ 208.97873 predictedDeepCCS 1.0 (2019) [M+Na]+ 227.0701469 predictedDarkChem Lite v0.1.0 [M+Na]+ 232.0948469 predictedDarkChem Lite v0.1.0 [M+Na]+ 215.07188 predictedDeepCCS 1.0 (2019)
Drug created at May 20, 2019 15:24 / Updated at June 12, 2020 16:53